Approval · Notice of Compliance 35716 · 2025
MYSTEP: Notice of Compliance 35716
Issued July 22, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35716
- Date
- July 22, 2025
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM). Product Monograph reformatted to the Master Template. Update to package insert
- Canadian reference product
- PLAN B (Foundation Consumer Healthcare, Llc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYSTEP | Not yet assigned | — |
Medicinal ingredients
- LEVONORGESTREL 1.5 MG per TAB